Floatz logo

VITAMIN D

Elderly Patients

Fondazione Italiana Linfomi - ETSmixturePhase 3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
81/ 100

Competitive context

15 Active assets in the Elderly Patients cohort.

Asset / SponsorPhaseRating
Capecitabine
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 3B
NORETHANDROLONE
University Hospital, Grenoble
Phase 3B
ROPIVACAINE
University Hospital, Clermont-Ferrand
Phase 2B
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Fondazione Italiana Linfomi - ETS
Phase 3B
Cyclophosphamide
Fondazione Italiana Linfomi - ETS
Phase 3B

View all 26 →

Same molecule, other indications

VITAMIN D is also rated in:

vitamin D deficiencyDormant
A
Indicative ·
83 / 100
View asset →
osteoporosisDormant
BBB
Indicative ·
76 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →